NOVARTIS CAPITAL P Profile

66989HAS7   64.98  0.36  0.55%   

Performance

Modest

 
Weak
 
Strong

Odds Of Default

Below Average

 
High
 
Low
NOVARTIS CAP CORP 2.75 percent 14Aug2050 is a Senior Unsecured Note issued by the corporate entity on the 11th of February 2020. NOVARTIS is trading at 64.98 as of the 23rd of March 2025, a 0.55% down since the beginning of the trading day. The bond's open price was 65.34. NOVARTIS has about a 37 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Ratings for NOVARTIS CAPITAL P are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 23rd of December 2024 and ending today, the 23rd of March 2025. Click here to learn more.

Moving against NOVARTIS Bond

  0.62HROWM Harrow Health, 11875PairCorr
  0.5PGLSX Global Multi StrategyPairCorr
  0.37ANPMF Andean Precious MetalsPairCorr
  0.32AEM Agnico Eagle MinesPairCorr

NOVARTIS Bond Highlights

Business ConcentrationNOVARTIS CAPITAL P Corporate Bond, Financial, Financial Services (View all Sectors)
Sub Product AssetCORP
Next Call Date14th of February 2050
Coupon Payment FrequencySemi-Annual
CallableYes
Sub Product Asset TypeCorporate Bond
NameNOVARTIS CAP CORP 2.75 percent 14Aug2050
C U S I P66989HAS7
Offering Date11th of February 2020
Coupon2.75
Debt TypeSenior Unsecured Note
I S I NUS66989HAS76
Yield To Maturity5.301
Price63.68
NOVARTIS CAPITAL P (66989HAS7) is traded in USA.

NOVARTIS CAPITAL P Risk Profiles

NOVARTIS Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in NOVARTIS without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Correlation Analysis Now

   

Correlation Analysis

Reduce portfolio risk simply by holding instruments which are not perfectly correlated
All  Next Launch Module

Other Information on Investing in NOVARTIS Bond

NOVARTIS financial ratios help investors to determine whether NOVARTIS Bond is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NOVARTIS with respect to the benefits of owning NOVARTIS security.